IM Cannabis (IMCC) Competitors $2.08 +0.08 (+4.00%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends IMCC vs. NNVC, COCP, BFRG, INAB, TENX, FNCH, CGTX, CTXR, CVKD, and MIRAShould you be buying IM Cannabis stock or one of its competitors? The main competitors of IM Cannabis include NanoViricides (NNVC), Cocrystal Pharma (COCP), Bullfrog AI (BFRG), IN8bio (INAB), Tenax Therapeutics (TENX), Finch Therapeutics Group (FNCH), Cognition Therapeutics (CGTX), Citius Pharmaceuticals (CTXR), Cadrenal Therapeutics (CVKD), and MIRA Pharmaceuticals (MIRA). These companies are all part of the "pharmaceutical products" industry. IM Cannabis vs. NanoViricides Cocrystal Pharma Bullfrog AI IN8bio Tenax Therapeutics Finch Therapeutics Group Cognition Therapeutics Citius Pharmaceuticals Cadrenal Therapeutics MIRA Pharmaceuticals IM Cannabis (NASDAQ:IMCC) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation. Which has stronger earnings and valuation, IMCC or NNVC? IM Cannabis has higher revenue and earnings than NanoViricides. NanoViricides is trading at a lower price-to-earnings ratio than IM Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIM Cannabis$51.39M0.09-$7.04M-$3.41-0.61NanoViricidesN/AN/A-$8.29M-$0.76-1.96 Which has more risk and volatility, IMCC or NNVC? IM Cannabis has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, NanoViricides has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Do insiders and institutionals believe in IMCC or NNVC? 7.7% of IM Cannabis shares are held by institutional investors. Comparatively, 10.3% of NanoViricides shares are held by institutional investors. 5.9% of IM Cannabis shares are held by company insiders. Comparatively, 4.6% of NanoViricides shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community prefer IMCC or NNVC? IM Cannabis received 6 more outperform votes than NanoViricides when rated by MarketBeat users. Likewise, 42.86% of users gave IM Cannabis an outperform vote while only 0.00% of users gave NanoViricides an outperform vote. CompanyUnderperformOutperformIM CannabisOutperform Votes642.86% Underperform Votes857.14% NanoViricidesOutperform VotesNo VotesUnderperform Votes57100.00% Is IMCC or NNVC more profitable? NanoViricides has a net margin of 0.00% compared to IM Cannabis' net margin of -25.55%. NanoViricides' return on equity of -84.63% beat IM Cannabis' return on equity.Company Net Margins Return on Equity Return on Assets IM Cannabis-25.55% -129.86% -23.63% NanoViricides N/A -84.63%-76.49% Does the media refer more to IMCC or NNVC? In the previous week, IM Cannabis' average media sentiment score of 0.00 equaled NanoViricides'average media sentiment score. Company Overall Sentiment IM Cannabis Neutral NanoViricides Neutral SummaryIM Cannabis beats NanoViricides on 8 of the 12 factors compared between the two stocks. Ad InvestorPlaceWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.This market shakeup is going to be much more intense. Get IM Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IMCC vs. The Competition Export to ExcelMetricIM CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.64M$371.97M$5.13B$9.07BDividend YieldN/AN/A4.93%4.23%P/E Ratio-0.6132.5689.7417.19Price / Sales0.095.651,115.29116.95Price / CashN/A10.6642.8237.86Price / Book0.461.884.774.78Net Income-$7.04M-$50.37M$120.04M$225.60M7 Day Performance-15.79%-3.56%-1.92%-1.23%1 Month Performance-25.98%-7.00%11.46%3.36%1 Year Performance3.42%-6.41%30.52%16.60% IM Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IMCCIM Cannabis0.0474 of 5 stars$2.08+4.0%N/A+3.4%$4.64M$51.39M-0.61340Gap DownNNVCNanoViricidesN/A$1.48flatN/A+40.6%$20.64MN/A-1.9520COCPCocrystal Pharma2.6583 of 5 stars$2.02+5.9%$7.00+246.5%+19.0%$20.55MN/A-1.1210Positive NewsBFRGBullfrog AI0.7327 of 5 stars$2.35+5.9%N/A-24.8%$20.48M$60,000.00-2.864News CoverageINABIN8bio3.6424 of 5 stars$0.28-1.1%$7.75+2,652.1%-80.7%$20.41MN/A-0.3820Gap DownTENXTenax Therapeutics1.4593 of 5 stars$5.84-0.7%$16.00+174.0%-76.7%$19.91MN/A0.009News CoverageFNCHFinch Therapeutics GroupN/A$11.75-2.1%N/A+251.4%$18.87M$110,000.00-1.36190News CoverageCGTXCognition Therapeutics2.8994 of 5 stars$0.45-6.2%$8.00+1,673.8%-62.9%$18.74MN/A-0.4920Analyst ForecastNews CoverageCTXRCitius Pharmaceuticals1.6605 of 5 stars$2.58-7.5%$100.00+3,776.0%-86.2%$18.65MN/A-0.4720Gap DownCVKDCadrenal Therapeutics1.7091 of 5 stars$11.00-1.8%$18.00+63.6%N/A$18.25MN/A-1.684News CoverageGap UpMIRAMIRA Pharmaceuticals2.6036 of 5 stars$1.10-1.8%$14.00+1,172.7%+0.5%$18.22MN/A-2.002Analyst RevisionNews Coverage Related Companies and Tools Related Companies NNVC Competitors COCP Competitors BFRG Competitors INAB Competitors TENX Competitors FNCH Competitors CGTX Competitors CTXR Competitors CVKD Competitors MIRA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IMCC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMCC Stock Alerts